2021

1. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

   The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274